Director, Regulatory Affairs Advertising, Labeling, and Promotion
2 weeks ago
Company Overview:
Beam Therapeutics is a clinical stage biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of potential therapeutic editing strategies that Beam has used to advance a diversified portfolio of base editing programs, including four programs to the clinic. Beam's lead program, BEAM-101 has recently demonstrated clinical validation in Sickle cell disease through upregulation of fetal hemoglobin in patients. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
Beam is seeking a Director of Regulatory Affairs – Advertising, Labeling, and Promotion to progress advanced genetic medicines in a fast paced and dynamic biotech environment. The person will be responsible for leading all regulatory labeling activities for Beam's hematology programs including creation of documents (e.g. CDS, USPI) and processes.
Responsibilities:
- Lead the creation, review, and approval of critical regulatory labeling documents including Core Data Sheet and Regional Labels for Beam hematology programs in alignment with Target Product Profiles.
- Lead labeling negotiations between Beam and health authorities as part of marketing authorization applications.
- Create regulatory labeling processes and associated SOPs, Work Instructions, and any other required documentation.
- Represent Regulatory Affairs as part of the Promotional Review Process.
- Incorporate the evolving global regulatory requirements and guidance's with respect to gene editing and gene therapy, rare disease, and prescription drug labeling.
- Provide innovative regulatory approaches, solutions and guidance to cross-functional teams while mitigating regulatory risks.
- Guide and assist on the planning, preparation, writing and submission of regulatory documentation.
- Manage project plans and timelines to ensure all projects are prioritized appropriately and milestones and goals are met on time.
- Provide regulatory due diligence as required.
- Supervise and mentor direct reports.
Qualifications:
- BS required, an advanced degree (i.e. MS, PharmD, PhD, MD) is a plus.
- A minimum of 6 years of experience working in Regulatory Affairs Advertising, Labeling, and Promotion; ideally 15 plus years in the biotech industry with at least 8 years in regulatory affairs.
- Record of success with interactions with Regulatory Agencies and Health Authorities as part of label negotiations and label updates.
- Comprehensive knowledge of US and global regulatory procedures and practices.
- Extensive experience with regulatory documents and filings (IND, CTA/IMPD, BLA, MAA, PIP).
- Strong strategic thinking and problem-solving skills.
- Experience in representing programs to internal and external stakeholders.
- Ability to develop collaborative working relationships internally as well as externally with physicians, expert consultants, and contracted vendors.
- Excellent written/verbal communication skills, attention to detail, organizational skills.
- Demonstrated ability to mentor and manage.
-
Director, Regulatory Affairs
7 hours ago
Cambridge, Massachusetts, United States Alnylam Pharmaceuticals Full timeOverviewThe Director, Regulatory Affairs for U.S. Advertising and Promotion (USAP) will provide strategic regulatory advice to internal stakeholders regarding tactics and communications related to Alnylam's marketed products, investigational treatments, and disease areas to healthcare providers, patients, payers, and other audiences. A critical aspect of...
-
Director, Regulatory Affairs
6 days ago
Cambridge, Massachusetts, United States City Therapeutics Full timeReporting to the SVP, Head of Regulatory Affairs, the Director, Regulatory Affairs – Global Regulatory Lead will serve as the primary global regulatory strategist for assigned products across all phases of development and commercialization. This individual will be responsible for developing and implementing global regulatory strategies, leading...
-
Director, CMC Regulatory Affairs
2 weeks ago
Cambridge, Massachusetts, United States City Therapeutics Full time $200,000 - $250,000 per yearReporting to the SVP, Head of Regulatory Affairs, the Director of CMC Regulatory Affairs will be responsible for leading Chemistry, Manufacturing, and Controls (CMC) regulatory strategy and execution for products in the development pipeline. This role will work independently to provide strategic leadership on global regulatory submissions and ensure...
-
Director, Regulatory Affairs Strategy
3 days ago
Cambridge, Massachusetts, United States BlueRock Therapeutics Full timeWho is BlueRock?BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson's disease and OpCT-001 for the treatment...
-
Director of Medical Affairs
2 weeks ago
Cambridge, Massachusetts, United States Cognito Therapeutics Full timeDirector, Medical Affairs, Cognito Therapeutics, Inc.Location: Boston, MA, Full-timeCompany DescriptionCognito Therapeutics, Inc. is a venture-backed (Morningside Ventures, FoundersX, IAG, Starbloom) late clinical stage company translating scientific findings from MIT into therapeutic approaches for brain health, including Alzheimer's disease and other...
-
Cambridge, Massachusetts, United States Novartis Full timeSummaryThe Regulatory Diagnostics Manager (RDM)Regulatory Diagnostics Associate Director (RDAD) for Precision Diagnostics is responsible for implementation of strategic plans for development of diagnostics, including Companion Diagnostics (CDx), as they pertain to the Novartis innovative medicines portfolio, including its marketed products. The RD...
-
Cambridge, Massachusetts, United States Ipsen Full time $160,000 - $210,000Title:Associate Director, Business Ethics, Medical Affairs & NeuroscienceCompany:Ipsen Biopharmaceuticals Inc.About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs...
-
Director, ELEVIDYS Patient Marketing
2 weeks ago
Cambridge, Massachusetts, United States Sarepta Therapeutics Full timeWhy Sarepta? Why Now?The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. In 2023, we launched our fourth therapy and the first ever gene therapy to treat...
-
Director, ELEVIDYS Patient Marketing
5 days ago
Cambridge, Massachusetts, United States Sarepta Therapeutics Full timeWhy Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. In 2023, we launched our fourth therapy and the first ever gene therapy to...
-
Senior Director, DMD Patient Marketing
9 hours ago
Cambridge, Massachusetts, United States Sarepta Therapeutics Full timeWhy Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. In 2023, we launched our fourth therapy and the first ever gene therapy to...